The TGA could reschedule MDMA and psilocybin — what that means for ASX-listers
A rescheduling decision could help introduce psychedelics to the psychiatrist’s office — and they’ve got off-the-charts potential to treat mental...
Stay updated with breaking news from Psychedelic Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A rescheduling decision could help introduce psychedelics to the psychiatrist’s office — and they’ve got off-the-charts potential to treat mental...
2 minute read A new study by researchers at Yale University has shown that a single dose of psilocybin given to mice prompted an immediate and long-lasting increase in connections between neurons. Psilocybin is a naturally occurring compound found in magic mushrooms and has been touted as a potential treatment for depression in recent years. However, the mechanics of exactly how psilocybin works in the brain and how long beneficial results might last is still unclear. The research found that the compound increases the density of dendritic spines, small protrusions found on nerve cells that ai...
Compass Pathways, the UK-based mental health care company that's innovating new mental health treatments, recently announced that it had been granted ...
Research suggests psychedelic substances like "magic mushrooms" do have potential medicinal benefits, including for treating depression and PTSD.
The global renaissance of psychedelic drugs in the treatment of mental health gains further legitimacy in Australia as psychologists sign up for clinical trials